Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
Clinical trial NCT00654186 · COMPLETED
Trial details
- NCT number
- NCT00654186
- Sponsor
- Oncology Specialists, S.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2012-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.